346 related articles for article (PubMed ID: 18467000)
1. Health state utility scores in advanced non-small cell lung cancer.
Doyle S; Lloyd A; Walker M
Lung Cancer; 2008 Dec; 62(3):374-80. PubMed ID: 18467000
[TBL] [Abstract][Full Text] [Related]
2. Health state utilities for non small cell lung cancer.
Nafees B; Stafford M; Gavriel S; Bhalla S; Watkins J
Health Qual Life Outcomes; 2008 Oct; 6():84. PubMed ID: 18939982
[TBL] [Abstract][Full Text] [Related]
3. Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.
Manser RL; Wright G; Byrnes G; Hart D; Conron M; Carter R; McLachlan SA; Campbell DA
Lung Cancer; 2006 Aug; 53(2):217-29. PubMed ID: 16765475
[TBL] [Abstract][Full Text] [Related]
4. Health utility values associated with diabetic retinopathy.
Lloyd A; Nafees B; Gavriel S; Rousculp MD; Boye KS; Ahmad A
Diabet Med; 2008 May; 25(5):618-24. PubMed ID: 18346157
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients surviving non-small cell lung cancer.
Grutters JP; Joore MA; Wiegman EM; Langendijk JA; de Ruysscher D; Hochstenbag M; Botterweck A; Lambin P; Pijls-Johannesma M
Thorax; 2010 Oct; 65(10):903-7. PubMed ID: 20861294
[TBL] [Abstract][Full Text] [Related]
6. Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer.
Rolke HB; Bakke PS; Gallefoss F
Respir Med; 2008 Oct; 102(10):1460-7. PubMed ID: 18590954
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer.
Fallowfield LJ; Harper P
Lung Cancer; 2005 Jun; 48(3):365-77. PubMed ID: 15893006
[TBL] [Abstract][Full Text] [Related]
8. Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change.
Matza LS; Yurgin N; Boye KS; Malley K; Shorr JM
Curr Med Res Opin; 2007 Sep; 23(9):2051-62. PubMed ID: 17651535
[TBL] [Abstract][Full Text] [Related]
9. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
[TBL] [Abstract][Full Text] [Related]
10. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in end-stage COPD and lung cancer patients.
Habraken JM; ter Riet G; Gore JM; Greenstone MA; Weersink EJ; Bindels PJ; Willems DL
J Pain Symptom Manage; 2009 Jun; 37(6):973-81. PubMed ID: 19394792
[TBL] [Abstract][Full Text] [Related]
12. Using preference-based measures to assess quality of life in stuttering.
Bramlett RE; Bothe AK; Franic DM
J Speech Lang Hear Res; 2006 Apr; 49(2):381-94. PubMed ID: 16671851
[TBL] [Abstract][Full Text] [Related]
13. Measuring health state preferences for hemophilia: development of a disease-specific utility instrument.
Wasserman J; Aday LA; Begley CE; Ahn C; Lairson DR
Haemophilia; 2005 Jan; 11(1):49-57. PubMed ID: 15660989
[TBL] [Abstract][Full Text] [Related]
14. The effects of spirituality on well-being of people with lung cancer.
Meraviglia MG
Oncol Nurs Forum; 2004; 31(1):89-94. PubMed ID: 14722592
[TBL] [Abstract][Full Text] [Related]
15. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
[TBL] [Abstract][Full Text] [Related]
16. Health state utilities in gastroesophageal reflux disease patients with heartburn: a study in Germany and Sweden.
Kartman B; Gatz G; Johannesson M
Med Decis Making; 2004; 24(1):40-52. PubMed ID: 15005953
[TBL] [Abstract][Full Text] [Related]
17. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.
Iyer S; Taylor-Stokes G; Roughley A
Lung Cancer; 2013 Aug; 81(2):288-93. PubMed ID: 23561304
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and health status of dyads of women with lung cancer and family members.
Sarna L; Cooley ME; Brown JK; Williams RD; Chernecky C; Padilla G; Danao LL
Oncol Nurs Forum; 2006 Nov; 33(6):1109-16. PubMed ID: 17149394
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting.
Chouaid C; Agulnik J; Goker E; Herder GJ; Lester JF; Vansteenkiste J; Finnern HW; Lungershausen J; Eriksson J; Kim K; Mitchell PL
J Thorac Oncol; 2013 Aug; 8(8):997-1003. PubMed ID: 23787802
[TBL] [Abstract][Full Text] [Related]
20. The impact of anchor point on utilities for 5 common ophthalmic diseases.
Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
